Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q4NX
|
|||
| Former ID |
DNCL002667
|
|||
| Drug Name |
FANG vaccine
|
|||
| Synonyms |
FANG (TN)
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 3 | [1], [2] | |
| Ewing sarcoma [ICD-11: 2B52; ICD-9: 170] | Phase 2/3 | [1], [2], [3], [4] | ||
| Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2/3 | [1], [4] | ||
| Adjuvant ovarian cancer [ICD-11: 2C73; ICD-10: C56] | Phase 2 | [5] | ||
| Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 2 | [3] | ||
| Breast cancer [ICD-11: 2C60-2C65] | Phase 1 | [2] | ||
| Therapeutic Class |
Anticancer Agents
|
|||
| Company |
Gradalis Carrollton, TX
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 5 | ClinicalTrials.gov (NCT01453361) Phase II FANG in Advanced Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.